FDA approves quarterly siRNA for myasthenia gravis
-
By
-
Mouj Hijazi
-
November 19, 2026
-
2 min
By
Mouj Hijazi
November 19, 2026
Several FDA decisions across multiple specialties are expected this month.
July 30, 2026
Clinical studies showed reductions in circulating thyroid hormone levels and changes in heart rate and systolic blood pressure.
September 29, 2026